References

2. Dunbar, L. A.; Caplan, M. J. Eur. J. Cell Biol. 2000, 79, 557-563.

4. Sadee, Wi; Drubbisch, V; Amidon, G. L. Pharm. Res. 1995, 12, 1823-1837.

5. Paulsen, I. T; Sliwinski, M. K.; Nelissen, B.; Goffeau, A.; Saier, M. H., Jr. FEBS Lett. 1998, 430, 116-125.

6. Ward, A.; Hoyle, C.; Palmer, S.; O'Reilly, J.; Griffith, J.; Pos, M.; Morrison, S.; Poolman, B.; Gwynne, M.; Henderson, P. J. Mol. Microbiol. Biotechnol. 2001, 3, 193-200.

7. Dassa, E.; Bouige, P Res. Microbiol. 2001, 152, 211-229.

8. Hediger, M. A.; Romero, M. F; Peng, J. B.; Rolfs, A.; Takanaga, H.; Bruford, E. A. Pflugers Arch. 2004, 447, 465-468. 8a. HUGO Gene Nomenclature Committee. http://www.gene.ucl.ac.uk/nomenclature (accessed June 2006).

8b. Transport Classification Database. http://www.tcdb.org (accessed June 2006).

9. Ozawa, N.; Shimizu, T.; Morita, R.; Yokono, Y; Ochiai, T.; Munesada, K.; Ohashi, A.; Aida, Y; Hama, Y; Taki, K.; Maeda, K.; Kusuhara, H.; Sugiyama, Y Pharm. Res. 2004, 21, 2133-2134.

10. Tusnady, G. E.; Sarkadi, B.; Simon, I.; Varadi, A. FEBS Lett. 2006, 580, 1017-1022.

11. Zhang, E. Y; Knipp, G. T; Ekins, S.; Swaan, P W Drug Metab. Rev. 2002, 34, 709-750.

12. Hagenbuch, B.; Meier, P J. Biochim. Biophys. Acta. 2003, 160, 91-118.

13. Walker, J. E.; Saraste, M.; Runswick, M. J.; Gay, N. J. EMBO J. 1982, 1, 945-951.

14. Gottesman, M. M.; Fojo, T; Bates, S. E. Nat. Rev. Cancer 2002, 2, 48-58.

15. Leslie, E. M.; Deeley, R. G.; Cole, S. P. Toxicol. Appl. Pharmacol. 2005, 204, 216-237.

16. Biedler, J. L.; Riehm, H. Cancer Res. 1970, 30, 1174-1184.

17. Juliano, R. L.; Ling, V Biochim. Biophys. Acta 1976, 455, 152-162.

18. Schinkel, A. H. Semin. Cancer Biol. 1997, 8, 161-170.

19. Schinkel, A. H.; Jonker, J. W Adv. Drug Deliv. Rev. 2003 , 55, 3-29.

20. Litman, T.; Skovsgaard, T; Stein, Wi D. J. Pharmacol. Exp. Ther. 2003, 307, 846-853.

21. Breedveld, P; Beijnen, J. H.; Schellens, J. H. Trends Pharmacol. Sci. 2006, 27, 17-24.

22. Schinkel, A. H. Adv Drug Deliv. Rev. 1999, 36, 179-194.

23. Marzolini, C.; Paus, E.; Buclin, T.; Kim, R. B. Clin. Pharmacol. Ther. 2004, 75, 13-33.

24. Roberts, R. L.; Joyce, P. R.; Mulder, R. T; Begg, E. J.; Kennedy, M. A. Pharmacogenom. J. 2002, 21, 91-196.

25. De Luca, V; Mundo, E.; Trakalo, J.; Wong, G. W.; Kennedy, J. L. Pharmacogenom. J. 2003, 3, 297-299.

26. Yi, S. Y; Hong, K. S.; Lim, H. S.; Chung, J. Y; Oh, D. S.; Kim, J. R.; Jung, H. R.; Cho, J. Y; Yu, K. S.; Jang, I. J.; Shin, S. G. Clin. Pharmacol. Ther. 2004, 76, 418-427.

27. Drozdzik, M.; Bialecka, M.; Mysliwiec, K.; Honczarenko, K.; Stankiewicz, J.; Sych, Z. Pharmacogenetics 2003, 13, 259-263.

28. Siddiqui, A.; Kerb, R.; Weale, M. E.; Brinkmann, U.; Smith, A.; Goldstein, D. B.; Wood, N. Wi; Sisodiya, S. M. N. Engl. J. Med. 2003, 348, 1442-1448.

29. Fardel, O.; Payen, L.; Courtois, A.; Vernhet, L.; Lecureur, V Toxicology 2001, 167, 37-46.

30. Childs, S.; Yeh, R. L.; Hui, D.; Ling, V Cancer Res. 1998, 58, 4160-4167.

31. Fattinger, K.; Funk, C.; Pantze, M.; Weber, C.; Reichen, J.; Stieger, B.; Meier, P J. Clin. Pharmacol. Ther. 2001, 69, 223-231.

32. Cole, S. P; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Science 1992, 258, 1650-1654.

33. Borst, P; Evers, R.; Kool, M.; Wijnholds, J. J. Natl. Cancer Inst. 2000, 92, 1295-1302.

34. Kruh, G. D.; Zeng, H.; Rea, P A.; Liu, G.; Chen, Z. S.; Lee, K.; Belinsky, M. G. J. Bioenerg. Biomembr. 2001, 33, 493-501.

35. Kruh, G. D.; Belinsky, M. G. Oncogene 2003, 22, 7537-7552.

36. Leier, I.; Jedlitschky, G.; Buchholz, U.; Cole, S. P; Deeley, R. G.; Keppler, D. J. Biol. Chem. 1994, 269, 27807-27810.

37. Leslie, E. M.; Mao, Q.; Oleschuk, C. J.; Deeley, R. G.; Cole, S. P. Mol. Pharmacol. 2001, 59, 1171-1180.

38. Godinot, N.; Iversen, P W; Tabas, L.; Xia, X.; Williams, D. C.; Dantzig, A. H.; Perry, W L., Jr. Mol. Cancer Ther. 2003, 2, 307-316.

39. Lorico, A.; Rappa, G.; Finch, R. A.; Yang, D.; Flavell, R. A.; Sartorelli, A. C. Cancer Res. 1997, 57, 5238-5242.

40. Wijnholds, J.; Evers, R.; van Leusden, M. R.; Mol, C. A.; Zaman, G. J.; Mayer, U.; Beijnen, J. H.; van der Valk, M.; Krimpenfort, P; Borst, P Nat. Med. 1997, 3, 1275-1279.

41. Wijnholds, J.; deLange, E. C.; Scheffer, G. L.; van den Berg, D. J.; Mol, C. A.; van der Valk, M.; Schinkel, A. H.; Scheper, R. J.; Breimer, D. D.; Borst, P J. Clin. Invest. 2000, 105, 279-285.

42. Paulusma, C. C.; Bosma, P. J.; Zaman, G. J.; Bakker, C. T; Otter, M.; Scheffer, G. L.; Scheper, R. J.; Borst, P.; Oude Elferink, R. P Science 1996, 271, 1126-1128.

43. Kitamura, T; Jansen, P.; Hardenbrook, C.; Kamimoto, Y; Gatmaitan, Z.; Arias, I. M. Proc. Natl. Acad. Sci. USA 1990, 87, 3557-3561.

44. Dietrich, C. G.; de Waart, D. R.; Ottenhoff, R.; Bootsma, A. H.; van Gennip, A. H.; Elferink, R. P Carcinogenesis 2001, 22, 805-811.

45. Dietrich, C. G.; Geier, A.; Oude Elferink, R. P. Gut 2003, 52, 1788-1795.

46. Kool, M.; de Haas, M.; Scheffer, G. L.; Scheper, R. J.; van Eijk, M. J.; Juijn, J. A.; Baas, F; Borst, P Cancer Res. 1997, 57, 3537-3547.

47. Miller, D. S.; Nobmann, S. N.; Gutmann, H.; Toeroek, M.; Drewe, J.; Fricker, G. Mol. Pharmacol. 2000, 58, 1357-1367.

48. Dombrowski, S. M.; Desai, S. Y; Marroni, M.; Cucullo, L.; Goodrich, K.; Bingaman, W; Mayberg, M. R.; Bengez, L.; Janigro, D. Epilepsia 2001, 42, 1501-1506.

49. Potschka, H.; Fedrowitz, M.; Loscher, W J. Pharmacol. Exp. Ther. 2003, 306, 124-131.

50. Belinsky, M. G.; Bain, L. J.; Balsara, B. B.; Testa, J. R.; Kruh, G. D. J. Natl. Cancer Inst. 1998, 90, 1735-1741.

51. Zelcer, N.; van de, W K.; Hillebrand, M.; Sarton, E.; Kuil, A.; Wielinga, P. R.;Tephly,T; Dahan,A.; Beijnen, J. H.; Borst, P Proc. Natl. Acad. Sci. USA 2005, 102, 7274-7279.

52. Cherrington, N. J.; Slitt, A. L.; Maher, J. M.; Zhang, X. X.; Zhang, J.; Huang, W; Wan, Y J.; Moore, D. D.; Klaassen, C. D. DrugMetab. Dispos.

2003, 31, 1315-1319.

53. Lang, T; Hitzl, M.; Burk, O.; Mornhinweg, E.; Keil, A.; Kerb, R.; Klein, K.; Zanger, U. M.; Eichelbaum, M.; Fromm, M. F Pharmacogenetics

54. Jedlitschky, G.; Burchell, B.; Keppler, D. J. Biol. Chem. 2000, 275, 30069-30074.

55. Borst, P; Balzarini, J.; Ono, N.; Reid, G.; de Vries, H.; Wielinga, P.; Wijnholds, J.; Zelcer, N. Antiviral Res. 2004, 62, 1-7.

56. Rius, M.; Nies, A. T; Hummel-Eisenbeiss, J.; Jedlitschky, G.; Keppler, D. Hepatology 2003, 38, 374-384.

57. Leggas, M.; Adachi, M.; Scheffer, G. L.; Sun, D.; Wielinga, P.; Du, G.; Mercer, K. E.; Zhuang, Y; Panetta, J. C.; Johnston, B.; Scheper, R. J.; Stewart, C. F; Schuetz, J. D. Mol. Cell Biol. 2004, 24, 7612-7621.

58. Doyle, L. A.; Yang, W; Abruzzo, L. V; Krogmann, T; Gao, Y; Rishi, A. K.; Ross, D. D. Proc. Natl. Acad. Sci. USA 1998, 95, 15665-15670.

59. Miyake, K.; Mickley, L.; Litman, T.; Zhan, Z.; Robey, R.; Cristensen, B.; Brangi, M.; Greenberger, L.; Dean, M.; Fojo, T; Bates, S. E. Cancer Res. 1999, 59, 8-13.

60. Allikmets, R.; Schriml, L. M.; Hutchinson, A.; Romano-Spica, V; Dean, M. Cancer Res. 1998, 58, 5337-5339.

61. Mao, Q.; Unadkat, J. D. AAPS J. 2005, 7, E118-E133.

62. Jonker, J. W; Buitelaar, M.; Wagenaar, E.; Van Der Valk, M. A.; Scheffer, G. L.; Scheper, R. J.; Plosch, T; Kuipers, F; Elferink, R. P; Rosing, H.; Beijnen, J. H.; Schinkel, A. H. Proc. Natl. Acad. Sci. USA 2002, 99, 15649-15654.

63. Ahmed-Belkacem, A.; Pozza, A.; Munoz-Martinez, F; Bates, S. E.; Castanys, S.; Gamarro, F; Di Pietro, A.; Perez-Victoria, J. M. Cancer Res.

2005, 65, 4852-4860.

64. Jonker, J. W; Smit, J. W; Brinkhuis, R. F; Maliepaard, M.; Beijnen, J. H.; Schellens, J. H.; Schinkel, A. H. J. Natl. Cancer Inst. 2000, 92, 1651-1656.

65. Breedveld, P.; Zelcer, N.; Pluim, D.; Sonmezer, O.; Tibben, M. M.; Beijnen, J. H.; Schinkel, A. H.; van Tellingen, O.; Borst, P; Schellens, J. H. Cancer Res. 2004, 64, 5804-5811.

66. van Herwaarden, A. E.; Schinkel, A. H. Trends Pharmacol. Sci. 2006, 27, 10-16.

67. Jonker, J. W; Merino, G.; Musters, S.; van Herwaarden, A. E.; Bolscher, E.; Wagenaar, E.; Mesman, E.; Dale, T C.; Schinkel, A. H. Nat. Med. 2005, 11, 127-129.

68. Merino, G.; Jonker, J. W; Wagenaar, E.; van Herwaarden, A. E.; Schinkel, A. H. Mol. Pharmacol. 2005, 67, 1758-1764.

69. Cervenak, J.; Andrikovics, H.; Ozvegy-Laczka, C.; Tordai, A.; Nemet, K.; Varadi, A.; Sarkadi, B. Cancer Lett. 2006, 234, 62-72.

70. Zamber, C. P; Lamba, J. K.; Yasuda, K.; Farnum, J.; Thummel, K.; Schuetz, J. D.; Schuetz, E. G. Pharmacogenetics 2003, 13, 19-28.

71. Sparreboom, A.; Gelderblom, H.; Marsh, S.; Ahluwalia, R.; Obach, R.; Principe, P; Twelves, C.; Verweij, J.; McLeod, H. L. Clin. Pharmacol. Ther. 2004, 76, 38-44.

72. Wright, E. M.; Turk, E.; Zabel, B.; Mundlos, S.; Dyer, J. J. Clin. Invest. 1991, 88, 1435-1440.

73. Wong, M. H.; Oelkers, P.; Dawson, P A. J. Biol. Chem. 1995, 270, 27228-27234.

74. Hagenbuch, B.; Gao, B.; Meier, P J. News Physiol. Sci. 2002, 17, 231-234.

75. Ballatori, N.; Hammond, C. L.; Cunningham, J. B.; Krance, S. M.; Marchan, R. Toxicol. Appl. Pharmacol. 2005, 204, 238-255.

76. Hagenbuch, B.; Meier, P J. Pflugers Arch 2004, 447, 653-665.

77. Shitara, Y; Sato, H.; Sugiyama, Y Ann. Rev. Pharmacol. Toxicol. 2005, 45, 689-723.

78. Masuda, S. DrugMetab Pharmacokinet. 2003, 18, 91-103.

79. Unadkat, J. D.; Dahlin, A.; Vijay, S. Curr. DrugMetab. 2004, 5, 125-131.

80. Grundemann, D.; Gorboulev, V; Gambaryan, S.; Veyhl, M.; Koepsell, H. Nature 1994, 372, 549-552.

81. Gorboulev, V; Ulzheimer, J. C.; Akhoundova, A.; Ulzheimer-Teuber, I.; Karbach, U.; Quester, S.; Baumann, C.; Lang, F; Busch, A. E.; Koepsell, H. DNA Cell Biol. 1997, 16, 871-881.

82. Wu, X.; Kekuda, R.; Huang, W; Fei, Y J.; Leibach, F H.; Chen, J.; Conway, S. J.; Ganapathy, V J. Biol. Chem. 1998, 273, 32776-32786.

83. Jonker, J. W.; Schinkel, A. H. J. Pharmacol. Exp. Ther. 2004, 308, 2-9.

84. Meijer, D. K.; Mol, W E.; Muller, M.; Kurz, G. J. Pharmacokinet. Biopharm. 1990, 18, 35-70.

85. Wright, S. H. Toxicol. Appl. Pharmacol. 2005, 204, 309-319.

86. Koepsell, H. Trends Pharmacol. Sci. 2004, 25, 375-381.

87. Urakami, Y; Nakamura, N.; Takahashi, K.; Okuda, M.; Saito, H.; Hashimoto, Y; Inui, K. FEBS Lett. 1999, 461, 339-342.

88. Verhaagh, S.; Schweifer, N.; Barlow, D. P; Zwart, R. Genomics 1999, 55, 209-218.

89. Jonker, J. W; Wagenaar, E.; Van Eijl, S.; Schinkel, A. H. Mol. Cell Biol. 2003, 23, 7902-7908.

90. Wang, D. S.; Kusuhara, H.; Kato, Y; Jonker, J. W; Schinkel, A. H.; Sugiyama, Y Mol. Pharmacol. 2003, 63, 844-848.

91. Enomoto, A.; Wempe, M. F; Tsuchida, H.; Shin, H. J.; Cha, S. H.; Anzai, N.; Goto, A.; Sakamoto, A.; Niwa, T; Kanai, Y; Anders, M. W; Endou, H. J. Biol. Chem. 2002, 277, 36262-36271.

92. Tamai, I.; Yabuuchi, H.; Nezu, J.; Sai, Y; Oku, A.; Shimane, M.; Tsuji, A. FEBS Lett. 1997, 419, 107-111.

93 . Wu, X. ; Huang, W ; Prasad, P. D . ; Seth, P ; Rajan, D . P. ; Leibach, F H . ; Chen, J . ; Conway, S . J . ; Ganapathy, V J. Pharmacol. Exp. Ther. 1999, 290, 1482-1492.

94. Burckhardt, G.; Wolff, N. A. Am. J. Physiol. Renal Physiol. 2000, 278, F853-F866.

95. Sweet, D. H. Toxicol. Appl. Pharmacol. 2005, 204, 198-215.

96. Enomoto, A.; Endou, H. Clin. Exp. Nephrol. 2005, 9, 195-205.

97. Sekine, T; Watanabe, N.; Hosoyamada, M.; Kanai, Y; Endou, H. J. Biol. Chem. 1997, 272, 18526-18529.

98. Robertson, E. E.; Rankin, G. O. Pharmacol. Ther. 2006, 109, 399-412.

99. Daniel, H.; Rubio-Aliaga, I. Am. J. Physiol. Renal Physiol. 2003, 284, F885-F892.

100. Sakata, K.; Yamashita, T; Maeda, M.; Moriyama, Y; Shimada, S.; Tohyama, M. Biochem. J. 2001, 356, 53-60.

101. Shu, C.; Shen, H.; Teuscher, N. S.; Lorenzi, P J.; Keep, R. F; Smith, D. E. J. Pharmacol. Exp. Ther. 2002, 301, 820-829.

102. Rubio-Aliaga, I.; Frey, I.; Boll, M.; Groneberg, D. A.; Eichinger, H. M.; Balling, R.; Daniel, H. Mol. Cell Biol. 2003, 23, 3247-3252.

103. Yang, C. Y; Dantzig, A. H.; Pidgeon, C. Pharm. Res. 1999, 16, 1331-1343.

104. Pastor-Anglada, M.; Cano-Soldado, P.; Molina-Arcas, M.; Lostao, M. P.; Larrayoz, I.; Martinez-Picado, J.; Casado, F. J. Virus Res. 2005, 107, 151-164.

105. Gray, J. H.; Owen, R. P; Giacomini, K. M. Pflugers Arch. 2004, 447, 728-734.

106. Ritzel, M. W; Yao, S. Y; Huang, M. Y; Elliott, J. F; Cass, C. E.; Young, J. D. Am. J. Physiol. 1997, 272, C707-C714.

107. Wang, J.; Su, S. F; Dresser, M. J.; Schaner, M. E.; Washington, C. B.; Giacomini, K. M. Am. J. Physiol. 1997, 273, F1058-F1065.

108. Ritzel, M. W; Ng, A. M.; Yao, S. Y; Graham, K.; Loewen, S. K.; Smith, K. M.; Ritzel, R. G.; Mowles, D. A.; Carpenter, P; Chen, X. Z.; Karpinski, E.; Hyde, R. J.; Baldwin, S. A.; Cass, C. E.; Young, J. D. J. Biol. Chem. 2001, 276, 2914-2927.

108a. http://www.pharmgkb.org/ (accessed June 2006) and http://www.pharmacogenetics.ucsf.edu (accessed June 2006).

109. Baldwin, S. A.; Beal, P R.; Yao, S. Y; King, A. E.; Cass, C. E.; Young, J. D. Pflugers Arch. 2004, 447, 735-743.

110. Yao, S. Y; Ng, A. M.; Sundaram, M.; Cass, C. E.; Baldwin, S. A.; Young, J. D. Mol. Membr. Biol. 2001, 18, 161-167.

111. Yao, S. Y; Ng, A. M.; Vickers, M. F; Sundaram, M.; Cass, C. E.; Baldwin, S. A.; Young, J. D. J. Biol. Chem. 2002, 277, 24938-24948.

112. Lai, Y; Tse, C. M.; Unadkat, J. D. J. Biol. Chem. 2004, 279, 4490-4497.

113. Ito, K.; Suzuki, H.; Horie, T; Sugiyama, Y Pharm. Res. 2005, 22, 1559-1577.

114. van de Water, F M.; Masereeuw, R.; Russel, F G. Drug Metab. Rev. 2005, 37, 443-471.

115. Cummins, C. L.; Jacobsen, W; Benet, L. Z. J. Pharmacol. Exp. Ther. 2002, 300, 1036-1045.

116. Hill, G.; Cihlar, T; Oo, C.; Ho, E. S.; Prior, K.; Wiltshire, H.; Barrett, J.; Liu, B.; Ward, P Drug Metab. Dispos. 2002, 30, 13-19.

117. Izzedine, H.; Launay-Vacher, V; Deray, G. AIDS 2005, 19, 455-462.

118. Thomas, J.; Wang, L.; Clark, R. E.; Pirmohamed, M. Blood 2004, 104, 3739-3745.

119. Cisternino, S.; Bourasset, F; Archimbaud, Y; Semiond, D.; Sanderink, G.; Scherrmann, J. M. Br. J. Pharmacol. 2003, 138, 1367-1375.

120. Wandel, C.; Kim, R. B.; Guengerich, F P.; Wood, A. J. Drug Metab. Dispos. 2000, 28, 895-898.

121. Dresser, G. K.; Bailey, D. G. Eur. J. Clin. Invest. 2003, 33, 10-16.

122. Endres, C. J.; Hsiao, P; Chung, F S.; Unadkat, J. D. Eur. J. Pharm. Sci. 2006, 27, 501-517.

123. Tachibana-Iimori, R.; Tabara, Y.; Kusuhara, H.; Kohara, K.; Kawamoto, R.; Nakura, J.; Tokunaga, K.; Kondo, I.; Sugiyama, Y.; Miki, T. Drug Metab. Pharmacokinet. 2004, 19, 375-380.

124. Tsuji, A.; Tamai, I. Pharm. Res. 1996, 13, 963-977.

125. Halestrap, A. P.; Meredith, D. Pflugers Arch. 2004, 447, 619-628.

126. Anderle, P; Sengstag, T; Mutch, D. M.; Rumbo, M.; Praz, V; Mansourian, R.; Delorenzi, M.; Williamson, G.; Roberts, M. A. BMC Genomics 2005, 6, 69.

127. Takano, M.; Yumoto, R.; Murakami, T. Pharmacol. Ther. 2006, 109, 137-161.

128. Katsura, T; Inui, K. Drug Metab. Pharmacokinet. 2003, 18, 1-15.

129. Sai, Y Drug Metab. Pharmacokinet. 2005, 20, 91-99.

130. Chandra, P; Brouwer, K. L. Pharm. Res. 2004, 21, 719-735.

131. Hirano, M.; Maeda, K.; Shitara, Y; Sugiyama, Y J. Pharmacol. Exp. Ther. 2004, 311, 139-146.

132. Niemi, M.; Neuvonen, P. J.; Hofmann, U.; Backman, J. T.; Schwab, M.; Lutjohann, D.; von Bergmann, K.; Eichelbaum, M.; Kivisto, K. T. Pharmacogenet. Genomics 2005, 15, 303-309.

133. Niemi, M.; Backman, J. T.; Kajosaari, L. I.; Leathart, J. B.; Neuvonen, M.; Daly, A. K.; Eichelbaum, M.; Kivisto, K. T.; Neuvonen, P. J. Clin. Pharmacol. Ther. 2005, 77, 468-478.

134. Koepsell, H.; Endou, H. Pflugers Arch 2004, 447, 666-676.

135. Nozawa, T; Sugiura, S.; Nakajima, M.; Goto, A.; Yokoi, T.; Nezu, J.; Tsuji, A.; Tamai, I. Drug Metab. Dispos. 2004, 32, 291-294.

136. Fehrenbach, T; Cui, Y; Faulstich, H.; Keppler, D. Naunyn Schmiedebergs Arch. Pharmacol. 2003, 368, 415-420.

137. Shitara, Y; Hirano, M.; Sato, H.; Sugiyama, Y J. Pharmacol. Exp. Ther. 2004, 311, 228-236.

138. Hedman, A.; Angelin, B.; Arvidsson, A.; Beck, O.; Dahlqvist, R.; Nilsson, B.; Olsson, M.; Schenck-Gustafsson, K. Clin. Pharmacol. Ther. 1991, 49, 256-262.

139. Ho, R. H.; Kim, R. B. Clin. Pharmacol. Ther. 2005, 78, 260-277.

140. Graff, C. L.; Pollack, G. M. Pharm. Res. 2005, 22, 86-93.

141. Hosoya, K.; Tomi, M. Biol. Pharm. Bull. 2005, 28, 1-8.

142. Obligacion, R.; Murray, M.; Ramzan, I. J. Androl. 2006, 27, 138-150.

143. Augustine, L. M.; Markelewicz, R. J., Jr.; Boekelheide, K.; Cherrington, N. J. Drug Metab. Dispos. 2005, 33, 182-189.

144. Cisternino, S.; Mercier, C.; Bourasset, F; Roux, F; Scherrmann, J. M. Cancer Res. 2004, 64, 3296-3301.

145. Kusuhara, H.; Sugiyama, Y NeuroRx 2005, 2, 73-85.

146. Ohtsuki, S. Biol. Pharm. Bull. 2004, 27, 1489-1496.

147. Graff, C. L.; Pollack, G. M. Curr. Drug Metab. 2004, 5, 95-108.

148. Mikkaichi, T; Suzuki, T.; Onogawa, T.; Tanemoto, M.; Mizutamari, H.; Okada, M.; Chaki, T; Masuda, S.; Tokui, T; Eto, N.; Abe, M.; Satoh, F; Unno, M.; Hishinuma, T; Inui, K.; Ito, S.; Goto, J.; Abe, T Proc. Natl. Acad. Sci. USA 2004, 101, 3569-3574.

149. Sasaki, M.; Suzuki, H.; Ito, K.; Abe, T; Sugiyama, Y J. Biol. Chem. 2002, 277, 6497-6503.

150. Pritchard, J. B.; Miller, D. S. Toxicol. Appl. Pharmacol. 2005, 204, 256-262.

151. Khamdang, S.; Takeda, M.; Babu, E.; Noshiro, R.; Onozato, M. L.; Tojo, A.; Enomoto, A.; Huang, X. L.; Narikawa, S.; Anzai, N.; Piyachaturawat, P.; Endou, H. Eur. J. Pharmacol. 2003, 465, 1-7.

152. Jung, K. Y; Takeda, M.; Shimoda, M.; Narikawa, S.; Tojo, A.; Kim, D. K.; Chairoungdua, A.; Choi, B. K.; Kusuhara, H.; Sugiyama, Y; Sekine, T; Endou, H. Life Sci. 2002, 70, 1861-1874.

153. Ciarimboli, G.; Ludwig, T.; Lang, D.; Pavenstadt, H.; Koepsell, H.; Piechota, H. J.; Haier, J.; Jaehde, U.; Zisowsky, J.; Schlatter, E. Am. J. Pathol. 2005, 167, 1477-1484.

154. Izzedine, H.; Launay-Vacher, V; Deray, G. Am. J. Kidney Dis. 2005, 45, 804-817.

155. Miller, D. S. J. Pharmacol. Exp. Ther. 2001, 299, 567-574.

156. Hasannejad, H.; Takeda, M.; Taki, K.; Shin, H. J.; Babu, E.; Jutabha, P; Khamdang, S.; Aleboyeh, M.; Onozato, M. L.; Tojo, A.; Enomoto, A.; Anzai, N.; Narikawa, S.; Huang, X. L.; Niwa, T; Endou, H. J. Pharmacol. Exp. Ther. 2004, 308, 1021-1029.

157. Amidon, G. L.; Lennernas, H.; Shah, V P; Crison, J. R. Pharm. Res. 1995, 12, 413-420.

158. Wu, C. Y; Benet, L. Z. Pharm. Res. 2005, 22, 11-23.

Biography

Jean-Michel Scherrmann, PharmD, PhD, is Professor and Chair at the Department of Clinical Pharmacy and Pharmacokinetics, Faculty of Pharmacy, the University of Paris 5. He received his PharmD and PhD in analytical radiochemistry from the University René Descartes at Paris. He currently leads the Neuropsychopharmacology Unit at the French Institute of Health and Medical Research (INSERM) and the National Center of Scientific Research (CNRS). Professor Scherrmann has made major contributions to the development of drug radioimmunoassay, drug detoxification by immunotherapy, and drug redistribution concepts in pharmacokinetics. He pioneered the first clinical application of colchicine immunotherapy in acute colchicine overdose, and is now focusing his research on the role of drug transporters in neuropharmacokinetics and drug delivery strategies to the brain. His work has resulted in two patents, 290 scientific articles, 45 book chapters, and more than 300 presentations. He has served on the editorial boards of several journals in the analytical and pharmaceutical sciences. He has mentored over 30 postgraduate and 44 doctoral students. Professor Scherrmann has been a recipient of the 1992 American Academy of Clinical Toxicology Award and the 1999 French National Academy of Medicine Achievement Award. He is a Fellow of the American Association of Pharmaceutical Scientists and a member of the French National Academy of Pharmacy.

© 2007 Elsevier Ltd. All Rights Reserved Comprehensive Medicinal Chemistry II

No part of this publication may be reproduced, stored in any retrieval system or transmitted ISBN (set): 0-08-044513-6 in any form by any means electronic, electrostatic, magnetic tape, mechanical, photocopying, recording or otherwise, without permission in writing from the publishers ISBN (Volume 5) 0-08-044518-7; pp. 51-85

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment